December 17, 2025: Federal Litigation Created for People Who Lost Their Vision After Taking Ozempic On December 15, 2025, the Joint Panel on Multidistrict Litigation (JPML) approved a request to consolidate lawsuits filed by people who experienced vision loss after taking Ozempic and other GLP-1 drugs
One was to find something that could protect it, the second was to eliminate the enzyme that destroys it and the third was to make it more stable (Molteni)
DPP-4=dipeptidyl peptidase-4
By boosting lipid metabolism and reducing oxidative damage, vitamin C supports a healthier liver, minimizing the risk of long-term complications associated with fat accumulation
The result: GLP-1 users feel less hungry, have a more muted blood sugar response after eating, and experience less mental chatter around hunger and cravingsall of which contribute to weight loss